Pharmaceutical Raw Material Rebamipide 99% CAS 90098-04-7

Model NO.
TGY202306100702
Service
OEM
Grade
Pharmaceutical Grade
MOQ
Any Quantitiy
Sample
Available
Shelf Life
24 Months Properly
Certificate
ISO9001:2008
Storage
Cool Dry Area
Test Method
USP;GMP
Molecular Weight
370.79
Molecular Formula
C19h15cln2o4
Coa
Available
Assay
99%
Appearance
White Powder
Transport Package
Boil Bag
Specification
HPLC 99%
Trademark
TGY
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29225090
Production Capacity
5000kg/Month
Reference Price
$ 22.50 - 85.50

Product Description

The Leader Manufacturer of  Powder-TGY Bioteach

Pharmaceutical raw material Rebamipide 99% CAS 90098-04-7


Pharmaceutical Raw Material Rebamipide 99% CAS 90098-04-7

 

Name Rebamipide
CAS 90098-04-7
MF C19H15ClN2O4
MW 370.79
MP 288-290°C dec.
Storage temp -20°C Freezer
Assay 99% Min.
Appearance White Powder
Usage It is used for treating stomach ulcers.
It is a kind of novel anti-ulcer drugs.

Rebamipide   an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.


Don't hesitate to contact us for latest COA


Pharmaceutical Raw Material Rebamipide 99% CAS 90098-04-7

Rebamipide is used in a number of Asian countries including Japan, South Korea, and China. Studies have shown that rebamipide can fight the damaging effects of NSAIDs on the GIT mucosa, and more recently, the small intestine.

 

It has also been studied for the treatment of Behçet's disease.

 

It was shown to successfully treat pouchitis in a single-N study after first line therapies for the condition were unsuccessful.

 

Some studies have shown effectiveness in presbyacusis (age-related hearing loss).

 

It has also been shown to alleviate signs and symptoms of dry eyes in a randomised controlled trial although this is not yet widely available clinically.

 

PNEUTEC.IT, 2023